Jonsson Comprehensive Cancer Center: Carcinoma, Renal Cell trials
The registry lists 13 Carcinoma, Renal Cell studies with Jonsson Comprehensive Cancer Center as lead sponsor. 3 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 6Phase 2 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney CancerNot yet recruitingNCT07716735Phase 1
- An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney CancerRecruitingNCT06447103Phase 2
- Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialRecruitingNCT06432036Phase 1/2
- Bortezomib in Treating Patients With Metastatic Kidney CancerCompletedNCT00276614Phase 2Results posted
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerWithdrawnNCT04603365Phase 2
- Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerTerminatedNCT04473781Phase 1
- Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
- Autologous Dendritic Cells in Treating Patients With Metastatic Kidney CancerCompletedNCT01826877Phase 1
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
- BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney CancerWithdrawnNCT00040989Phase 2
- Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney CancerCompletedNCT00006968Phase 1/2
- Vaccine Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00004880Phase 1